Immuno Oncology Talks podcast

Adoptive therapy with engineered T cell receptors

0:00
29:32
Manda indietro di 15 secondi
Manda avanti di 15 secondi

In the current, and fifth episode of the “Immuno Oncology Talks”, we discuss adoptive therapy with engineered T cell receptors, with Professor Reno Debets from the Erasmus MC Cancer Institute in the Netherlands. Professor Debets research aims to explore therapeutic strategies by developing and testing adoptive T cell therapy and understand and intervene with the cross-talk between tumor cells and T cells.

MAT-BE-2300064 (Ver 1.0) Jan 2023

Altri episodi di "Immuno Oncology Talks"